ABSTRACT
Introduction

Radiation was first described by Willhelm Conrad
Roentgen as a new type of beam in 1895 1 . After development of science radiation has been successfully used for cancer treatment in the world. Nevertheless it is well known that radiotherapy can cause adverse toxic effects on the surrounding tissues.
Gastrointestinal tract is the second sensitive organ to radiation after bone marrow 2 . For this reason, radiotherapy (RT) application to abdominal region can cause a clinical tableu called acute radiation enteritis with inflammation, edema, epithelial degeneration, ulceration, decrease in mitotic activity and crypt abscess in gastrointestinal tractus 3, 4 . In clinical practice acute radiation enteritis can cause several intestinal symptoms such as bleeding, anorexia, nausea, vomiting and diarrhea, called gastrointestinal radiation syndrome 5, 6 .
Bacterial translocation is defined as the passage of viable endogenous bacteria and endotoxins from the gastrointestinal (GI) tract to extraintestinal sites, such as the mesenteric lymph node complex, liver, spleen, kidney and bloodstream 7, 8 . Recent literature showed that, a significantly increase in the bacterial overgrowth and translocation by destroying the intestinal mucosal barrier and affecting intestinal peristaltic movement is seen in the abdominal region affected by radiation 4, 8 . This complication can be seen approximately in 10-15% of the patients after abdominal radiation theraphy and is the most important limiting factor for the radiotherapy dose in the abdominopelvic region 9 .
In cancer treatment, there is an increasing need for developing new radioprotective agents to eliminate or minimize the radioactive damage by ionized radiation. Amifostine is an organic triphosphate with cytoprotective and antioxidant effects.
The protective activity of amifostine on tissues against chronic effects of radiation is controversial due to its short half-life period,
that is approximately eight minutes 10 . However, the radioprotective effect of amifostine against acute toxic effects of radiation was prooved on both breast, bladder, neck, head, ovary, and rectal cancers in many studies
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.
The protective effects of amifostine on different radiation types and doses in acute period were studied in recent literature, but there are no study evaluating effects of amifostine on bacterial overgrowth and translocation after acute radiation enteritis [12] [13] [14] . In our study, the effects of amifostine on both bacterial translocation and bacterial overgrowth in colonic flora after acute radiation enteritis were evaluated in a rat model.
Methods
This study was performed in DUSAM (Dicle University On the 5th day after radiation, laparotomy was performed under anesthesia as described above. After antisepsis, laparotomy performed with midline incision. Stool samples were obtained from the cecal content for coproculture while mesentery lymph tissues were dissected carefully in a sterile manner. Mesentery lymph tissue samples were homogenized in 1000 ml trypticase soy broth using disposable tissue grinders (Baxter, Chicago, IL) and 200 ml was plated on Columbia agar. All culture plates were evaluated after 48 hours incubation at 37°C. Plates were considered positive if any bacterial growth was noted. One gr of caecal samples were put into sterile tubes seperately. Rats were euthanased under general anesthesia. The collection of contents of caecum and cultivation was performed according to the method defined previously 15 . Samples were homogenized in stomacher by adding 9 ml of sterile saline. Serial tenfold dilutions were prepared up to 10 -9 from obtained main dilution. All prepared solutions were cultivated at the same time. Plate Count Agar (PCA) (Merck 1.05463, Germany), a general purpose media was used in determining the total mesophilic aerob bacterial (TMAB) count. All culture plates were evaluated after 48 hours incubation at 37°C and the results were recorded as CFU/g (colony forming unit/gram). Violet Red Bile Glucose Agar (VRBGA) (Oxoid CM 485, Hampshire, England) was used for counting enteric bacteria. After 24 hours of incubation at 37°C, all plates were evaluated by double layer pouring technique for red-violet colored colonies with 1-2 mm diameter and results were recorded as CFU/g. The data was statistically analyzed with SPSS 12.0 program. The differences between the groups were determined by Kruskal-Wallis test on TMAB and enteric bacterial counts from the inoculation of the cecal content. After performing benferroni correction the groups were compared with Mann-Whitney U test in pairs. p<0.005/6 (i.e. p<0.008) was considered to be significant. Number of rats in every group, with or without overgrowth in their mesentery lymph nodes were detected. Chi square test was performed to determine the difference between groups. Fisher's Exact test was used for verification and the difference of groups was admitted significant p<0.005.
Results
Radiation induced diarrhea and abdominal distension was observed after 24 hours in all rats in both group-2 and group-4 affected by radiation. These symptoms did not seen in rats in both group-1 and group-3. Mean bacterial count per gram was determined in stool samples from cecal content showed the bacterial overgrowth. The total mesophilic aerob bacterial counts (TMAB), minimum, maximum and mean enteric bacterial counts are shown in Table 2 .
The mean of TMAB isolated in stool samples taken from the caecum of rats were 30.7x10
6 in group-1, 248x10 6 in group-2, 47.6x10 6 in group-3 and 28.88x10 6 in group-4 ( Table 2 ). The mean of enteric bacterial counts were 0.4x10 6 , 6.72x10 6 , 2.25x10 6 and 1.36x10 6 in the groups, respectively (Table 2 ). There was a statistically significant increase in TMAB and enteric bacterial count in stool samples of group-2 compared to group-1 (TMAB p= 0.003, enteric bacteria p<0.001). There was no statistically significant increase in TMAB count but a significant increase was seen in enteric bacterial counts between groups 1 and 3 (TMAB p= 0.01, enteric bacteria p<0.001). A significant decrease detected both in TMAB counts and enteric bacterial counts after radiation in group-4 compared to group-2 (TMAB p= 0.007, enteric bacteria p= 0.005). When we examined the culture results of mesenteric lymph tissue samples of group-1, only one positive result was detected from a rat. All culture results were found positive in group-2. In the line of this data we can say that radiation significantly increased the bacterial translocation in rats (p= 0.001).
In group-3, two culture results were positive and in group-4, four culture results were positive. There was no statistically significant difference between groups 1 and 3. In comparison of group-2 and group-4, it was determined that amifostine decreased the bacterial translocation induced by radiation but the difference was not statistically significant (p= 0.077) ( Table 3) . 
Discussion
The damage caused by radiation on gastrointestinal mucosal barrier is the most important dose limiting factor in abdominopelvic radiotherapy for cancer treatment 9, 16 . This clinical tableu may appear with severe symptoms such as diarrhea, tenesmus and rectal bleeding 17 . A previous study reported that [18] [19] [20] [21] [22] Gy radiation dose range can cause acute diarrhea 18 . In our study diarrhea was observed after 24 hours in all the rats affected by radiation.
Gastrointestinal flora is a requirement for a healthy . In our study, a significant increase was seen in TMAB counts and enteric bacterial counst in the cecal content of rats after acute radiation enteritis in radiation group compared to the control group.
A great number of chemical agents and oral nutrients are used for decreasing mortality and morbidity of radiotherapy induced complications 3, 16, 22 . Although there are no study evaluating the protective effects of amifostine on bacterial overgrowth and translocation on gastrointestinal system after acute radiation enteritis. evaluation of protective effects of amifostine under different radiation types and doses in acute period were studied in recent literature.
In this experimental study, we determined that a statistically significant decrease in TMAB and enteric bacterial counts (bacterial overgrowth) after radiation in group 4 treated with amifostine compared to group-2 (TMAB p= 0.007, enteric bacteria p= 0.005). This is the first study conducted on this subject. Therefore we could not compare our data with other studies. Recent studies reported that ionized radiation can cause acute morphological changes in intestines in 24 to 48 hours and amifostine has some protective effects against these acute effects 23-26 . Our results showed that amifostine may decrease the bacterial overgrowth induced by radiation, in acute phase due to its expected protective effect on the intestinal mucosa.
In previous experimental animal models, it was showed that ionized radiation increased the bacterial translocation 16, 27 . In our study, bacterial overgrowth was detected in all samples of lymph nodules in rats of group-2 and it was statistically significant when we compared to group-1 (p= 0.001).
Free oxygen radicals, generated by the induction of oxidative stress after radiation, form the fundamental toxic and inflammatory process on normal tissues
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. It is expected that amifostine will decrease the bacterial translocation, however amifostine is considered to protect intestinal mucosal barrier due to its antioxidant and repairing characteristics on DNA fragmentation after radiation injury
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. In our study bacterial overgrowth was determined in 100% of cultures in group-2 affected by radiation, this percentage decreased to 50% in rats in group-4. Although there was no statistically significant difference between groups 2 and 4 (p= 0.077).
Conclusions
Amifostine can be a useful radioprotective agent in clinical practice after acute radiation enteritis. Our study showed that amifostine significantly decreased the bacterial overgrowth in the cecal content after high dose radiation. However, it was shown that amifostine do not provide a full protection on the damaged mucosal barrier under radiation but it may decrease the bacterial translocation in gastrointestinal system.
We consider that researchers will have increased interest in radioprotective effects of amifostine. There is a need to find out appropriate amifostine dose under different radiation applications avoiding bacterial translocation in gastrointestinal system.
